Latest Breaking News On - Andrew zhu - Page 9 : comparemela.com

I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI and GAITHERSBURG, Md., March 9, 2022 /PRNewswire/ I-Mab (the Company ) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company com.

United statesHong kongSan diegoXuejun liuAndrew zhuJian liExchange commissionAmerican association for cancer researchPrnewswire the company nasdaqAmerican associationCancer researchBoth innateAdaptive immunityNovel claudinPrivate securities litigation reform act

Business | Maryland Daily Record

Business | Maryland Daily Record
thedailyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailyrecord.com Daily Mail and Mail on Sunday newspapers.

John marinoAndrew zhuDavidj weberTheresab felderJingwu zangJohn longSungrid solutionsHarford leading edge training centerRatcliffe foundation on novNational institute of standardsUs supreme courtBiotechnology researchInstitute for bioscienceHarford community collegeRead moreRockville based institute

I-Mab executes senior management team s share purchase plan

I-Mab executes senior management team s share purchase plan
thedailyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailyrecord.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew zhuJingwu zangJielun zhuWeimin tangJohn longCompany americanChief financial officerChief strategy officer jielun zhuChief business officer

More News | Maryland Daily Record

More News | Maryland Daily Record
thedailyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailyrecord.com Daily Mail and Mail on Sunday newspapers.

John marinoAndrew zhuDavidj weberJingwu zangJohn longNational institute of standardsSungrid solutionsBiotechnology researchUs supreme courtInstitute for bioscienceStandard solar incLogos energyStandard solarKlees millCarroll countyRead more

I-Mab Announces Execution of Senior Management Team Share Purchase Plan

/PRNewswire/ I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization.

United statesHong kongSan diegoEmilie wuAndrew zhuGigi fengJingwu zangJohn longJielun zhuWeimin tangCompany americanPrnewswire the company nasdaqCompany adssPiacente group incExchange commissionChief financial officer john long